Identification of residues crucially involved in soluble guanylate cyclase activation.
Cardiovascular Research, Bayer HealthCare, Aprather Weg 18a, D-42096 Wuppertal, Germany.
Journal Article: FEBS Letters (impact factor: 3.54). 08/2006; 580(17):4205-13. DOI: 10.1016/j.febslet.2006.06.079
Abstract
Source: PubMed
Comments on this publication
ResearchGate members can add comments. Sign up now and post your comment!
Similar publications
Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo.
Molecular pharmacology. 72(5):1181-90.
Probing domain interactions in soluble guanylate cyclase.
Biochemistry. 50(20):4281-90.
NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.
British journal of pharmacology. 136(5):773-83.
ATP bimodal switch that regulates the ligand binding and signal transduction activities of the atrial natriuretic factor receptor guanylate cyclase.
Biochemical and biophysical research communications. 209(1):286-92.
Regulation of nitric oxide and soluble guanylyl cyclase.
Brain research bulletin. 62(6):505-15.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

